Kamil Majchrzak has been hit with a 13-month suspension on a doping violation.

Majchrzak, who reached a career-high ATP singles rating of 75 in February 2022, was examined by the ITIA on the Sofia Open in September 2022, the Kinoshita Group Japan Open in October 2022, and the FILA Open Seoul Challenger, additionally in October 2022. Majchrzak was additionally examined by the Polish Anti-Doping Agency (POLADA) in November 2022.

Raducanu: "Brutal" Tour Featuring Sharks

The International Tennis Integrity Agency introduced evaluation of the samples confirmed the presence of Prohibited Substance SARM S-22, metabolites of LGD-4033 and a PPARδ agonist - all non-Specified substances listed within the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytical Findings (AAFs) for non-Specified Substances carry a compulsory provisional suspension, and Majchrzak was provisionally suspended on November 30, 2022.

Majchrzak admitted the Anti-Doping Rule Violations, however claimed he didn't knowingly ingest Prohibited Substances. Majchrzak submitted that the AAFs had been the results of a contaminated complement, offering proof within the type of buy receipts and samples of the complement from the identical batch for testing.

The complement had been despatched for evaluation by each the Majchrzak and the ITIA, confirming the presence of the identical Prohibited Substances present in Majchrzak’s optimistic assessments.

The ITIA accepted that Majchrzak had not knowingly or deliberately ingested the Prohibited Substances, and additional mitigating proof contains the participant’s session with a dietician in regards to the complement and its components.

Majchrzak's suspension,which incorporates his time already served, will finish on December twenty ninth, 2023. Until then, he's banned from enjoying, teaching and even attending any tennis occasion.

Photo credit score: Corinne06/Wikimedia Commons 

Content Source: www.tennisnow.com